The formation of a protein corona is a significant aspect of in vivo complexity. When nanomaterials enter the bloodstream, they rapidly adsorb proteins onto their surface, forming a corona. This corona changes the identity and biological interactions of the nanomaterials, affecting their pharmacokinetics and cellular uptake. Understanding the composition and dynamics of the protein corona is essential for predicting the in vivo behavior of nanomaterials.
